Chiome Bioscience Inc. announced consolidated earnings results for the nine months ended September 30, 2018. For the nine months, the company reported net sales of JPY 142 million against JPY 186 million a year ago. Operating loss was JPY 932 million against JPY 574 million a year ago. Ordinary loss was JPY 927 million against JPY 575 million a year ago. Net loss was JPY 927 million against JPY 574 million a year ago. Net loss per share was JPY 34.63 against JPY 21.92 a year ago. Loss before taxes was JPY 925,581,000 against JPY 572,777,000 a year ago.

Chiome discloses only business forecasts for Drug Discovery Support Business; net sales JPY 220 million. There is no revision to the most recently announced forecasts of financial results.